RT @Brandon_Beaber: 21 year follow up of the BENEFIT (CIS) trial suggests a long term benefit of early treatment with disease modifying the…
21 year follow up of the BENEFIT (CIS) trial suggests a long term benefit of early treatment with disease modifying therapy, though this study has poor patient retention and serious biases https://t.co/w46Qbg694H
RT @OhioHealthMS: Yep. “Long-term follow-up of multiple sclerosis studies and outcomes from early treatment of clinically isolated syndrome…
RT @OhioHealthMS: Yep. “Long-term follow-up of multiple sclerosis studies and outcomes from early treatment of clinically isolated syndrome…
RT @OhioHealthMS: Yep. “Long-term follow-up of multiple sclerosis studies and outcomes from early treatment of clinically isolated syndrome…
RT @OhioHealthMS: Yep. “Long-term follow-up of multiple sclerosis studies and outcomes from early treatment of clinically isolated syndrome…
RT @OhioHealthMS: Yep. “Long-term follow-up of multiple sclerosis studies and outcomes from early treatment of clinically isolated syndrome…
RT @OhioHealthMS: Yep. “Long-term follow-up of multiple sclerosis studies and outcomes from early treatment of clinically isolated syndrome…
Yep. “Long-term follow-up of multiple sclerosis studies and outcomes from early treatment of clinically isolated syndrome in the BENEFIT 11 study” https://t.co/iM4BkFrHgG